Lichenyuan (Talk | contribs) |
|||
Line 310: | Line 310: | ||
should be adopted, such as RNAi, to inhibit the bypass pathway.<br /> | should be adopted, such as RNAi, to inhibit the bypass pathway.<br /> | ||
</a> | </a> | ||
− | + | ||
<br /> | <br /> |
Revision as of 21:02, 1 November 2017